Research Bridge Partners

Cancer-Fighting Biotech to Move Research Operations to Dallas After ACS ‘Golden Ticket’ Win

by | Mar 24, 2025
Jibe Therapeutics is developing a next-generation cancer treatment that helps the immune system better recognize and attack tumors. As a result of its "Golden Ticket" pitch competition win, Jibe is relocating its research operations to Dallas' Pegasus Park.
MORE
American Cancer Society’s BrightEdge Golden Ticket Pitch Competition to Be Held at Pegasus Park
by | Oct 24, 2024
Oncology companies seeking seed-stage through Series A funding are invited to apply to the Golden Ticket Pitch Competition, which will be held on March 11, 2025.
MORE
Texas-Based Research Bridge Partners Taps New Board Leadership to Drive ‘High-Quality Investment Opportunities’ in Biomedical Innovation
by | Aug 9, 2024
With a new CEO and three seasoned industry veterans joining its board, Research Bridge Partners is focused on moving university innovations from the lab to the marketplace.

Last year, the Texas-based nonprofit, in collaboration with Lyda Hill Philanthropies, invested $4 million into North Texas’ UT Southwestern Medical Center, bolstering efforts to transform groundbreaking research into viable companies.
MORE
Research Bridge Partners and Lyda Hill Philanthropies Fuel UT Southwestern’s Biotech Spinouts With $4 Million Investment
by | Apr 20, 2023
The initial investment will support the commercialization of life science research, including identifying researchers with entrepreneurial mindsets, safeguarding intellectual property, and recruiting key executives.
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.